Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease
Table 5
Predicted probabilities of parasitological cure in mice chronically infected with T.cruzi, and required benznidazole exposures in plasma.